Trials / Completed
CompletedNCT04338308
New-DES vs BMS in SVG -1 Year Outcomes
New-generation Drug Eluting Stent vs. Bare Metal Stent in Saphenous Vein Graft - 1 Year Outcomes by a Propensity Score Ascertainment (SVG Baltic Registry)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 792 (actual)
- Sponsor
- Medical University of Silesia · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Data regarding the efficacy of the percutaneous coronary intervention (PCI) with new-designed drug-eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce. The primary objective was to compare one-year clinical outcomes of PCI in stenosis of SVG using new-DES vs. BMS in a real-world population. We carried out a multi-center registry comparing new-DES with BMS in all consecutive patients undergoing PCI of SVG. The primary composite endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | new-DES | with ot without embolic protection device |
| DEVICE | BMS | with ot without embolic protection device |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2015-10-01
- Completion
- 2020-03-01
- First posted
- 2020-04-08
- Last updated
- 2020-04-08
Locations
3 sites across 1 country: Poland
Source: ClinicalTrials.gov record NCT04338308. Inclusion in this directory is not an endorsement.